Geron

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Geron and other ETFs, options, and stocks.

About GERN

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies.

CEO

Dawn Carter Bir

CEODawn Carter Bir

Employees

229

Employees229

Headquarters

Foster City, California

HeadquartersFoster City, California

Founded

1990

Founded1990

Employees

229

Employees229

GERN Key Statistics

Market cap

800.44M

Market cap800.44M

Price-Earnings ratio

-5.55

Price-Earnings ratio-5.55

Dividend yield

—

Dividend yield—

Average volume

10.80M

Average volume10.80M

High today

$1.18

High today$1.18

Low today

$1.11

Low today$1.11

Open price

$1.13

Open price$1.13

Volume

9.86M

Volume9.86M

52 Week high

$4.84

52 Week high$4.84

52 Week low

$1.09

52 Week low$1.09

Analyst ratings

60%

of 10 ratings

Buy

60%

Hold

30%

Sell

10%

People also own

Based on the portfolios of people who own GERN. This list is generated using Robinhood data, and it’s not a recommendation.